In a large primary care data set, the CHA2DS2-VASc score leads to an almost universal recommendation for anticoagulation treatment in those aged ≥65 years with atrial fibrillation

Eur J Cardiovasc Nurs. 2023 Dec 14;22(8):769-772. doi: 10.1093/eurjcn/zvad002.
No abstract available

Keywords: Atrial fibrillation; General practice; Stroke prevention.

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Primary Health Care
  • Risk Assessment
  • Risk Factors
  • Stroke* / drug therapy
  • Stroke* / prevention & control

Substances

  • Anticoagulants